These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38073337)

  • 21. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
    Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
    Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterising people with focal drug-resistant epilepsy: A retrospective cohort study.
    Benoist C; Boccaletti S; Leach JP; Cattaneo A; Chaplin A; Antunes L; Heiman F; Sander JW
    Epilepsy Behav; 2023 Dec; 149():109540. PubMed ID: 38006844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of suicidality in children and adolescents with depressive disorders with and without epilepsy.
    Hague C; Waber D; Rotenberg A; Vega C
    Epilepsy Behav; 2023 Nov; 148():109467. PubMed ID: 37844439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression but not seizure factors or quality of life predicts suicidality in epilepsy.
    Hecimovic H; Santos JM; Carter J; Attarian HP; Fessler AJ; Vahle V; Gilliam F
    Epilepsy Behav; 2012 Aug; 24(4):426-9. PubMed ID: 22683245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression screening in pediatric epilepsy: evidence for the benefit of a behavioral medicine service in early detection.
    Guilfoyle SM; Monahan S; Wesolowski C; Modi AC
    Epilepsy Behav; 2015 Mar; 44():5-10. PubMed ID: 25597526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG; Burnside G; Appleton R; Smith D; Leach JP; Sills G; Tudur-Smith C; Plumpton CO; Hughes DA; Williamson PR; Baker G; Balabanova S; Taylor C; Brown R; Hindley D; Howell S; Maguire M; Mohanraj R; Smith PE
    Health Technol Assess; 2021 Dec; 25(75):1-134. PubMed ID: 34931602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seizure outcome in medically treated patients with adult-onset epilepsy and cerebral cavernous malformation.
    Oh H; Im K; Yang HR; Kim HJ; Koo YS; Lee SA
    Clin Neurol Neurosurg; 2023 Oct; 233():107951. PubMed ID: 37683297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiseizure medication treatment outcomes in new-onset pediatric epilepsy.
    Itamura S; Sasaki K; Fujii Y; Okano R
    Pediatr Int; 2023; 65(1):e15523. PubMed ID: 36912459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital.
    Wang S; Rotenberg A; Bolton J
    Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003615. PubMed ID: 30350354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical factors associated with late seizure remission after failed epilepsy surgery.
    Kaye LC; Poolos ZA; Miller JW; Poolos NP
    Epilepsy Behav; 2023 Jan; 138():109055. PubMed ID: 36543042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hopelessness in persons with epilepsy: Relationship with demographic, clinical, and social variables.
    Ciuffini R; Stratta P; Rossi R; Perilli E; Marrelli A
    Epilepsy Behav; 2019 Nov; 100(Pt A):106383. PubMed ID: 31574427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacokinetic model of antiseizure medication load to guide care in the epilepsy monitoring unit.
    Ghosn NJ; Xie K; Pattnaik AR; Gugger JJ; Ellis CA; Sweeney E; Fox E; Bernabei JM; Johnson J; Boccanfuso J; Litt B; Conrad EC
    Epilepsia; 2023 May; 64(5):1236-1247. PubMed ID: 36815252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perception of seizure severity and bothersome in refractory focal epilepsy.
    Tedrus GMAS; Augusto MN; Bonolo HPB
    Rev Neurol (Paris); 2022 Jun; 178(6):603-608. PubMed ID: 34920892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.